T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
The Greenbrier Companies
GBX
$1.42B
| $460K | ﹤0.01% |
25,958
+4,232
| +19% | +$100K |
|
|
DRRX
2027
DELISTED
DURECT Corp
DRRX
| $459K | ﹤0.01% |
29,644
+20,650
| +230% | +$396K |
|
|
KNL
2028
DELISTED
Knoll, Inc.
KNL
| $455K | ﹤0.01% |
44,102
+22,510
| +104% | +$448K |
|
2029
Oceaneering
OII
$5.11B
| $454K | ﹤0.01% |
154,373
+38,000
| +33% | +$397K |
|
|
VIA
2030
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $454K | ﹤0.01% |
14,478
-60
| -0.4% | -$2.63K |
|
|
NP
2031
DELISTED
Neenah, Inc. Common Stock
NP
| $452K | ﹤0.01% |
10,479
+169
| +2% | +$10K |
|
|
ENDP
2032
DELISTED
Endo International plc
ENDP
| $451K | ﹤0.01% |
121,924
-62,493
| -34% | -$317K |
|
2033
Center Bancorp
CNOB
$1.81B
| $449K | ﹤0.01% |
33,390
+204
| +0.6% | +$4.3K |
|
2034
Donnelley Financial Solutions
DFIN
$1.22B
| $449K | ﹤0.01% |
85,155
+43,810
| +106% | +$371K |
|
2035
StoneX
SNEX
$8.05B
| $449K | ﹤0.01% |
62,704
-3,463
| -5% | -$30.7K |
|
|
BIG
2036
DELISTED
Big Lots, Inc.
BIG
| $448K | ﹤0.01% |
31,488
+230
| +0.7% | +$5.2K |
|
2037
Lexicon Pharmaceuticals
LXRX
$1.04B
| $446K | ﹤0.01% |
228,475
+35,100
| +18% | +$104K |
|
|
ACIA
2038
DELISTED
Acacia Communications Inc
ACIA
| $445K | ﹤0.01% |
6,628
+2,235
| +51% | +$151K |
|
2039
Enviri
NVRI
$564M
| $444K | ﹤0.01% |
63,696
+1,110
| +2% | +$15.2K |
|
|
CNSL
2040
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $444K | ﹤0.01% |
97,526
-1,180
| -1% | -$6K |
|
|
LVGO
2041
DELISTED
Livongo Health, Inc. Common Stock
LVGO
| $443K | ﹤0.01% |
+15,511
| New | +$402K |
|
2042
Asbury Automotive
ABG
$3.78B
| $441K | ﹤0.01% |
7,982
+123
| +2% | +$10.7K |
|
2043
Park Aerospace
PKE
$811M
| $439K | ﹤0.01% |
34,877
+15,400
| +79% | +$226K |
|
2044
OneSpan
OSPN
$624M
| $438K | ﹤0.01% |
24,143
-23,521
| -49% | -$399K |
|
2045
ATN International
ATNI
$491M
| $437K | ﹤0.01% |
7,441
-3,722
| -33% | -$211K |
|
2046
Agilysys
AGYS
$3.25B
| $436K | ﹤0.01% |
26,080
+5,019
| +24% | +$137K |
|
2047
Dillards
DDS
$9.59B
| $436K | ﹤0.01% |
11,806
+73
| +0.6% | +$4.27K |
|
|
CXP
2048
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $436K | ﹤0.01% |
34,884
+127
| +0.4% | +$2.38K |
|
|
GTY
2049
Getty Realty Corp
GTY
$2.05B
| $435K | ﹤0.01% |
18,324
+833
| +5% | +$24.4K |
|
|
MAGN
2050
Magnera Corp
MAGN
$433M
| $427K | ﹤0.01% |
2,686
+21
| +0.8% | +$4.13K |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.